GB202206257D0 - Biomarkers of diabetic nephropathy - Google Patents

Biomarkers of diabetic nephropathy

Info

Publication number
GB202206257D0
GB202206257D0 GBGB2206257.4A GB202206257A GB202206257D0 GB 202206257 D0 GB202206257 D0 GB 202206257D0 GB 202206257 A GB202206257 A GB 202206257A GB 202206257 D0 GB202206257 D0 GB 202206257D0
Authority
GB
United Kingdom
Prior art keywords
biomarkers
diabetic nephropathy
nephropathy
diabetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2206257.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Randox Laboratories Ltd
Original Assignee
Randox Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Laboratories Ltd filed Critical Randox Laboratories Ltd
Priority to GBGB2206257.4A priority Critical patent/GB202206257D0/en
Publication of GB202206257D0 publication Critical patent/GB202206257D0/en
Priority to PCT/EP2023/060911 priority patent/WO2023208993A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
GBGB2206257.4A 2022-04-29 2022-04-29 Biomarkers of diabetic nephropathy Ceased GB202206257D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2206257.4A GB202206257D0 (en) 2022-04-29 2022-04-29 Biomarkers of diabetic nephropathy
PCT/EP2023/060911 WO2023208993A1 (en) 2022-04-29 2023-04-26 Biomarkers of diabetic nephropathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2206257.4A GB202206257D0 (en) 2022-04-29 2022-04-29 Biomarkers of diabetic nephropathy

Publications (1)

Publication Number Publication Date
GB202206257D0 true GB202206257D0 (en) 2022-06-15

Family

ID=81943882

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2206257.4A Ceased GB202206257D0 (en) 2022-04-29 2022-04-29 Biomarkers of diabetic nephropathy

Country Status (2)

Country Link
GB (1) GB202206257D0 (en)
WO (1) WO2023208993A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0874242B2 (en) 1997-04-21 2009-06-03 Randox Laboratories Ltd. Device and apparatus for the simultaneous detection of multiple analytes
CN104330574B (en) * 2008-11-10 2017-04-12 阿斯图特医药公司 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2406636B1 (en) * 2008-12-10 2018-11-07 Joslin Diabetes Center, Inc. Methods of diagnosing and predicting renal disease
GB201804648D0 (en) * 2018-03-22 2018-05-09 Randox Laboratories Ltd Combination biomarker

Also Published As

Publication number Publication date
WO2023208993A1 (en) 2023-11-02

Similar Documents

Publication Publication Date Title
GB201914193D0 (en) Digital biomarkers of movement for diagnosis
GB202206257D0 (en) Biomarkers of diabetic nephropathy
ZA202108391B (en) Biomarkers for predicting progression of intravenous leiomyomatosis
GB202107813D0 (en) Biomarker
EP4083627A4 (en) Prognostic biomarker of cancer
GB202103080D0 (en) Cancer biomarkers
GB202314954D0 (en) Biomarkers
GB202216295D0 (en) Biomarkers
GB202215749D0 (en) Biomarkers
GB202212826D0 (en) Biomarkers
GB202307768D0 (en) Use of cell free nucleosomes as biomarkers
GB202017987D0 (en) Biomarker of fibrosis
GB202005564D0 (en) Biomarker of fibrosis
GB202114655D0 (en) Biomarkers
GB202111201D0 (en) Biomarkers
GB202103951D0 (en) Biomarkers
GB202103140D0 (en) Biomarkers
GB202015056D0 (en) Biomarkers
GB202014190D0 (en) Biomarkers
GB202005435D0 (en) Biomarkers
GB202001361D0 (en) Biomarkers
GB202114656D0 (en) Biomarker
GB202112831D0 (en) Biomarker
GB202110365D0 (en) Biomarker
GB202216420D0 (en) Biomarkers of pregnancy loss

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)